K Lindqvist1, C Wallmofeldt2, E Holmén1,3, A Hammarberg3,4, M Kåberg5,6. 1. Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden. 2. Norra Stockholms Psykiatri (Psychiatry of Northern Stockholm), S:t Görans Hospital, Stockholm, Sweden. 3. Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 4. Stockholm Centre for Dependency Disorders, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden. 5. Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden. martin.kaberg@ki.se. 6. Department of Medicine Huddinge, Division of Infection and Dermatology, Karolinska Institutet, Karolinska University Hospital Huddinge, Sprututbytet, S:t Görans sjukhus, Akutvägen 29, 112 81, Stockholm, Sweden. martin.kaberg@ki.se.
Abstract
BACKGROUND AND AIMS: People who inject drugs may be particularly vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to underlying health problems, stigma and social vulnerabilities. Harm reduction services, including needle exchange programs (NEP), have been subjected to varying degrees of disruption in the world, especially in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Compared to responses in other countries, Sweden's initial strategy toward limiting the spread and impact of COVID-19 was less restrictive to its citizens with no imposed general societal lockdown. In this study, we investigate changes in drug use patterns, utilization of NEP associated health services, COVID-19 health literacy and the prevalence of SARS-CoV-2 antibodies among NEP clients in Stockholm during the COVID-19 pandemic. METHODS: NEP visits and services provided (needles/syringes, HIV and hepatitis C tests and treatment, naloxone distributed) and overall mortality among NEP clients between January 1 and October 31, 2020, were used for trend analyses in comparison with corresponding 2019 data. Between July 27 and October 2, 2020, NEP clients (n = 232) responded to a 27 item COVID-19 Health Literacy Questionnaire. SARS CoV-2 IgG antibody tests (n = 779) were performed between June 15 and October 31, 2020. RESULTS: During the COVID-19 pandemic number of clients, client visits, naloxone distribution and HCV tests remained stable compared to 2019, while distribution of needles/syringes increased (p < 0.0001); number of HIV tests and HCV treatments decreased (p < 0.05); and mortality decreased (< 0.01). Overall, the level of health literacy concerning transmission routes and protective measures was high. SARS-CoV-2 antibody prevalence was 5.4% (95% CI 4.0-7.2). CONCLUSIONS: The Stockholm NEP managed to maintain a high level of clients and services during the pandemic. In general, COVID-19 health literacy was adequate and the overall SARS-CoV-2 antibody prevalence was low compared to the general population, which highlights a need for prioritized and targeted COVID-19 vaccination among PWID.
BACKGROUND AND AIMS: People who inject drugs may be particularly vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to underlying health problems, stigma and social vulnerabilities. Harm reduction services, including needle exchange programs (NEP), have been subjected to varying degrees of disruption in the world, especially in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Compared to responses in other countries, Sweden's initial strategy toward limiting the spread and impact of COVID-19 was less restrictive to its citizens with no imposed general societal lockdown. In this study, we investigate changes in drug use patterns, utilization of NEP associated health services, COVID-19 health literacy and the prevalence of SARS-CoV-2 antibodies among NEP clients in Stockholm during the COVID-19 pandemic. METHODS: NEP visits and services provided (needles/syringes, HIV and hepatitis C tests and treatment, naloxone distributed) and overall mortality among NEP clients between January 1 and October 31, 2020, were used for trend analyses in comparison with corresponding 2019 data. Between July 27 and October 2, 2020, NEP clients (n = 232) responded to a 27 item COVID-19 Health Literacy Questionnaire. SARS CoV-2 IgG antibody tests (n = 779) were performed between June 15 and October 31, 2020. RESULTS: During the COVID-19 pandemic number of clients, client visits, naloxone distribution and HCV tests remained stable compared to 2019, while distribution of needles/syringes increased (p < 0.0001); number of HIV tests and HCV treatments decreased (p < 0.05); and mortality decreased (< 0.01). Overall, the level of health literacy concerning transmission routes and protective measures was high. SARS-CoV-2 antibody prevalence was 5.4% (95% CI 4.0-7.2). CONCLUSIONS: The Stockholm NEP managed to maintain a high level of clients and services during the pandemic. In general, COVID-19 health literacy was adequate and the overall SARS-CoV-2 antibody prevalence was low compared to the general population, which highlights a need for prioritized and targeted COVID-19 vaccination among PWID.
Entities:
Keywords:
COVID-19; Harm reduction; Health literacy; Needle exchange program; People who inject drugs; SARS-CoV-2
Authors: Leslie D Williams; Eunhye Lee; Carl Latkin; Mary Ellen Mackesy-Amiti; Maggie Kaufmann; Elizabeth Copulsky; Charlie Kaplan; Basmattee Boodram Journal: Int J Environ Res Public Health Date: 2022-04-28 Impact factor: 4.614
Authors: Steffanie A Strathdee; Daniela Abramovitz; Alicia Harvey-Vera; Carlos F Vera; Gudelia Rangel; Irina Artamonova; Antoine Chaillon; Caroline Ignacio; Alheli Calderon; Natasha K Martin; Thomas L Patterson Journal: PLoS One Date: 2021-11-22 Impact factor: 3.752
Authors: Fabio Lugoboni; Luigi Stella; Lorenzo Zamboni; Simone Campagnari; Francesca Fusina; Ernesto De Bernardis Journal: J Public Health Res Date: 2022-08-10
Authors: Rebecca McDonald; Desiree Eide; Katri Abel-Ollo; Lee Barnsdale; Ben Carter; Thomas Clausen; Ed Day; Francina Fonseca; Elin Holmén; Kirsten Horsburgh; Mike Kelleher; Martin Kåberg; Martin Ladenhauf; Andrew McAuley; Nicola Metrebian; Joanne Neale; Stephen Parkin; Kevin Ratcliffe; Chris Rintoul; Josie Smith; Viktorija Stifanoviciute; Marta Torrens; Henrik Thiesen; John Strang Journal: Int J Drug Policy Date: 2022-07-01
Authors: Rachel L Miller; Angela McLaughlin; Vincent Montoya; Junine Toy; Sarah Stone; John Harding; Richard H Liang; Jason Wong; Rolando Barrios; Julio S G Montaner; Jeffrey B Joy Journal: Lancet Reg Health Am Date: 2022-09-23